bf/NASDAQ:GRCL_icon.jpeg

NASDAQ:GRCL

Gracell Biotechnologies Inc.

  • Stock

USD

Last Close

10.24

21/02 21:00

Market Cap

965.02M

Beta: −1.83

Volume Today

6.37M

Avg: 131.30K

PE Ratio

−12.25

PFCF: -

Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
0.00
-
cash per share
5.75
-
15.97
177.69%
11.79
26.15%
27.86
136.31%
13.90
50.11%
company equity multiplier
62.32
-
1.61
97.41%
1.18
27.07%
1.13
4.24%
1.20
6.79%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
40.58K
-
dividend yield
ebit per revenue
-1.27K
-
ebt per ebit
0.97
-
0.95
2.74%
0.99
4.48%
0.97
1.40%
0.97
0.20%
effective tax rate
-0.03
-
0.05
266.25%
0.07
48.66%
-0.03
144.96%
-0.00
99.88%
enterprise value multiple
-61.26
-
-22.81
62.77%
-48.66
113.36%
-2.23
95.42%
-0.66
70.27%
fixed asset turnover
0.00
-
free cash flow per share
-3.70
-
-9.68
162.01%
-4.23
56.28%
-5.49
29.76%
-5.06
7.84%
gross profit margin
1
-
interest coverage
-99.49
-
-91.56
7.97%
-92.72
1.27%
inventory turnover
long term debt to capitalization
0.98
-
0.35
64.20%
0.06
83.07%
0.04
38.77%
0.04
1.68%
net income per ebt
1
-
0.95
4.68%
0.93
2.39%
1.03
10.84%
1.00
3.03%
net profit margin
-1.27K
-
operating cash flow per share
-3.12
-
-6.83
118.88%
-3.02
55.78%
-4.63
53.21%
-4.60
0.63%
operating profit margin
-1.27K
-
payables turnover
pretax profit margin
-1.23K
-
price fair value
1.43K
-
13.54
99.05%
13.07
3.45%
1.39
89.40%
1.21
12.69%
receivables turnover
0.01
-
return on assets
-0.41
-
-0.32
21.67%
-0.20
36.28%
-0.23
10.68%
-0.37
62.20%
return on capital employed
-0.44
-
-0.37
16.04%
-0.25
33.87%
-0.24
1.07%
-0.44
78.80%
return on equity
-25.51
-
-0.52
97.97%
-0.24
53.53%
-0.25
5.99%
-0.44
73.21%
total debt to capitalization
0.98
-
0.35
64.20%
0.11
68.31%
0.08
29.81%
0.12
49.97%

All numbers in USD (except ratios and percentages)